Publication Name	World Journal of Diabetes
Manuscript ID	89369
Country	United States

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon
Manuscript Source	Invited Manuscript
All Author List	Mahmoud Nassar, Ajay Chaudhuri, Husam Ghanim and Paresh Dandona
Funding Agency and Grant Number
Corresponding Author	Mahmoud Nassar, MD, MSc, PhD, Doctor, Doctor, Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, 705 Maple Road, Buffalo, NY 14221, United States. dr.nassar@aucegypt.edu
Key Words	Type 1 diabetes; Semaglutide; Glucagon-like peptide-1 receptor agonists; Insulin therapy; Autoimmune response; Blood glucose monitoring; Β-cell preservation; Early screening; Teplizumab; Randomized controlled trials
Core Tip	New research suggests a novel approach to treating type 1 diabetes (T1D) by using glucagon-like peptide-1 receptor agonists, specifically semaglutide, to significantly improve blood glucose control and potentially slow the progression of the disease in newly diagnosed patients. This strategy, which leads to less insulin dependence and better metabolic markers, could change the way T1D is managed in a big way. At the same time, the study supports early T1D risk screening, especially in groups with high risk, so that early interventions can be made, evaluating the benefits against the possible emotional and financial effects. This dual approach shows that there are bright futures for improving the lives of patients with T1D.
Citation	Nassar M, Chaudhuri A, Ghanim H, Dandona P. Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon. World J Diabetes 2024; 15(2): 133-136

Received	2023-11-03 10:12
Peer-Review Started	2023-11-03 10:14
First Decision by Editorial Office Director	2023-12-06 08:04
Return for Revision	2023-12-06 08:04
Revised	2023-12-17 17:46
Publication Fee Transferred
Second Decision by Editor	2024-01-08 00:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-01-16 05:33
Articles in Press	2024-01-16 05:33
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-30 02:58

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com